Interferon-induced activation state of circulating dendritic cells and monocytes triggered by yellow fever vaccination correlates with early protective antibody responses
Elena WinheimiD, Antonio Santos‐PeraliD, Tamara EhmiD, Linus RinkeiD, Sandra RiemeriD, Magdalena ZauchaiD, Sebastian GoreschiD, Lisa LehmanniD, Katharina EisenächeriD, Michael PritschiD, Giovanna Barba SpaethiD, Tobias StraubiD, Simon RothenfußeriD, Anne B. KrugiD
Abstract
Yellow fever vaccination provides long-lasting protection and is a unique model for studying the immune response to an acute RNA virus infection in humans. To elucidate the early innate immune events preceding the rapid generation of protective immunity, we performed transcriptome analysis of human blood dendritic cell (DC) and monocyte subpopulations before and 3, 7, 14 and 28 days after vaccination. We detected temporary upregulation of IFN-stimulated genes (ISG) in all DC and monocyte subsets on day 3 and 7 after vaccination as well as cell type specific responses and temporal dynamics. Single cell RNA sequencing revealed rapid appearance of activated DC and monocyte clusters dominated by ISGs, inflammatory chemokines and genes involved in antigen processing and presentation. This was confirmed by flow cytometric analysis in a large cohort of vaccinees. We identified SIGLEC1/CD169 upregulation as a sensitive indicator of the transient IFN-induced activation state elicited in DCs and monocytes by YF17D vaccination correlating with early protective IgM antibody responses.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 2.61
- Field percentile
- top 10%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- RIG-I-like receptor-dependent type I Interferon regulates antigen dose and activation in yellow fever vaccine 17D-infected antigen presenting cells
Magdalena Zaucha, Elena Winheim, … Anne Krug·bioRxiv·Oct 8, 2025
- Live attenuated YFV-17D vaccine induces robust B and T cell immunity in vaccine-draining lymph nodes
Rachel B Evans, Wen Shi Lee, … Adam K Wheatley·bioRxiv·Nov 5, 2026
- Longitudinal Profiling of CD4⁺ T Cell Responses Following de novo Yellow Fever Vaccination
Dzenis Gojak, Maria S. Kuznetsova, … Benson Ogunjimi·bioRxiv·Feb 28, 2026
- Mitochondrial Hyperactivity and Reactive Oxygen Species Drive Innate Immunity to the Yellow Fever Virus-17D Live-Attenuated Vaccine
Samantha G. Muccilli, Benjamin H. Schwarz, … Sonja M. Best·PLoS PathogensPeer-reviewed·Apr 21, 2025
- Kinetic patterns of single cell gene expression discriminate between the murine cellular responses to live attenuated and inactivated Yellow Fever vaccines
Budhaditya Chatterjee, Christopher T. Boughter, … Nevil J. Singh·bioRxiv·Nov 26, 2024
- Integrated single-cell analysis reveals interferon-driven immune signatures in a DENV1 human infection model.
Anne-Sofie Vermeersch, Thomas-Wolf Verdonckt, … Filip Van Nieuwerburgh·bioRxiv·Jan 5, 2026